Qifeng Ji

Changle West Road 169
Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Hypoxia-injured pulmonary vascular targeting and microenvironment-responsive nanoparticle to treat hypoxic pulmonary hypertension.

Hypoxia-injured pulmonary vascular targeting and microenvironment-responsive nanoparticle to treat hypoxic pulmonary hypertension.

Journal: Journal of nanobiotechnology

Published: December 18, 2025

Brain and Liver Dual-Targeting Oridonin Nanoparticles to Enhance Aβ Clearance for Alzheimer's Disease Therapy.

Brain and Liver Dual-Targeting Oridonin Nanoparticles to Enhance Aβ Clearance for Alzheimer's Disease Therapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 18, 2025

The enhanced cancer nanovaccine by bidirectionally blocking CXCL12/CXCR4 axis to inhibit the recurrence and metastasis of triple-negative breast cancer.

The enhanced cancer nanovaccine by bidirectionally blocking CXCL12/CXCR4 axis to inhibit the recurrence and metastasis of triple-negative breast cancer.

Journal: Molecular cancer

Published: May 08, 2025

Hybrid membrane-coated Cyclosporine A nanocrystals preventing secondary brain injury via alleviating neuroinflammatory and oxidative stress.

Hybrid membrane-coated Cyclosporine A nanocrystals preventing secondary brain injury via alleviating neuroinflammatory and oxidative stress.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: January 02, 2025

Automatic target-seeking nanoparticle inhibiting orthotopic drug-resistant colon cancer and liver metastases via regulating cancer cell adhesion and proliferation.

Automatic target-seeking nanoparticle inhibiting orthotopic drug-resistant colon cancer and liver metastases via regulating cancer cell adhesion and proliferation.

Journal: Journal of nanobiotechnology

Published: December 12, 2024

The Mitochondria-Targeted Micelle Inhibits Alzheimer's Disease Progression by Alleviating Neuronal Mitochondrial Dysfunction and Neuroinflammation.

The Mitochondria-Targeted Micelle Inhibits Alzheimer's Disease Progression by Alleviating Neuronal Mitochondrial Dysfunction and Neuroinflammation.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: September 22, 2024

Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reaction.

Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reaction.

Journal: Journal of nanobiotechnology

Published: October 27, 2023

Corrigendum to "Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges" [Redox Biol. 63 (2023) 102734].

Corrigendum to "Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges" [Redox Biol. 63 (2023) 102734].

Journal: Redox biology

Published: May 23, 2023

Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges.

Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges.

Journal: Redox biology

Published: March 30, 2023

Calcium phosphate hybrid micelles inhibit orthotopic bone metastasis from triple negative breast cancer by simultaneously killing cancer cells and reprogramming the microenvironment of bone resorption and immunosuppression.

Calcium phosphate hybrid micelles inhibit orthotopic bone metastasis from triple negative breast cancer by simultaneously killing cancer cells and reprogramming the microenvironment of bone resorption and immunosuppression.

Journal: Acta biomaterialia

Published: December 22, 2022

Cyclosporine A-loaded apoferritin alleviates myocardial ischemia-reperfusion injury by simultaneously blocking ferroptosis and apoptosis of cardiomyocytes.

Cyclosporine A-loaded apoferritin alleviates myocardial ischemia-reperfusion injury by simultaneously blocking ferroptosis and apoptosis of cardiomyocytes.

Journal: Acta biomaterialia

Published: September 20, 2022

Nano-Codelivery of Temozolomide and siPD-L1 to Reprogram the Drug-Resistant and Immunosuppressive Microenvironment in Orthotopic Glioblastoma.

Nano-Codelivery of Temozolomide and siPD-L1 to Reprogram the Drug-Resistant and Immunosuppressive Microenvironment in Orthotopic Glioblastoma.

Journal: ACS nano

Published: May 13, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026